SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hussain R. Yusuf, W. Craig Hooper, Scott D. Grosse, Christopher S. Parker, Sheree L. Boulet, Thomas L. Ortel, Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees, Thrombosis Research, 2015, 135, 1, 50

    CrossRef

  2. 2
    Sheng Yu, Kanako K. Kumamaru, Elizabeth George, Ruth M. Dunne, Arash Bedayat, Matey Neykov, Andetta R. Hunsaker, Karin E. Dill, Tianxi Cai, Frank J. Rybicki, Classification of CT pulmonary angiography reports by presence, chronicity, and location of pulmonary embolism with natural language processing, Journal of Biomedical Informatics, 2014, 52, 386

    CrossRef

  3. 3
    Signy V. Sveinsdottir, Peter J. Svensson, Gunnar Engström, Inflammatory plasma markers and risk for venous thromboembolism, Journal of Thrombosis and Thrombolysis, 2014, 38, 2, 190

    CrossRef

  4. 4
    Seoyoung C. Kim, Daniel H. Solomon, Jun Liu, Jessica M. Franklin, Robert J. Glynn, Sebastian Schneeweiss, Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis Initiating Disease-Modifying Antirheumatic Drugs, The American Journal of Medicine, 2014,

    CrossRef

  5. 5
    Ashwin N. Ananthakrishnan, Andrew Cagan, Vivian S. Gainer, Su-Chun Cheng, Tianxi Cai, Elizabeth Scoville, Gauree G. Konijeti, Peter Szolovits, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Isaac Kohane, Katherine P. Liao, Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology, 2014, 12, 11, 1905

    CrossRef

  6. 6
    Lydia M. Efird, Donald R. Miller, Arlene S. Ash, Dan R. Berlowitz, Al Ozonoff, Shibei Zhao, Joel I. Reisman, Guneet K. Jasuja, Adam J. Rose, Identifying the Risks of Anticoagulation in Patients with Substance Abuse, Journal of General Internal Medicine, 2013, 28, 10, 1333

    CrossRef

  7. 7
    Charles E. Mahan, Maxine D. Fisher, Roger M. Mills, Larry E. Fields, Judith J. Stephenson, An-Chen Fu, Alex C. Spyropoulos, Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population, Thrombosis Research, 2013, 132, 5, 520

    CrossRef

  8. 8
    J. I. Shen, A. A. Mitani, T. I. Chang, W. C. Winkelmayer, Use and safety of heparin-free maintenance hemodialysis in the USA, Nephrology Dialysis Transplantation, 2013, 28, 6, 1589

    CrossRef

  9. 9
    Y.-B. Yu, J.-P. Gau, C.-Y. Liu, M.-H. Yang, S.-C. Chiang, H.-C. Hsu, Y.-C. Hong, L.-T. Hsiao, J.-H. Liu, T.-J. Chiou, P.-M. Chen, T.-S. Lee, L.-F. Chou, C.-H. Tzeng, T.-J. Chen, A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system, Thrombosis and Haemostasis, 2012, 108, 2, 225

    CrossRef

  10. You have free access to this content10
    Ryan M. Carnahan, Kevin G. Moores, Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned, Pharmacoepidemiology and Drug Safety, 2012, 21,
  11. You have free access to this content11
    Ryan M. Carnahan, Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research, Pharmacoepidemiology and Drug Safety, 2012, 21,
  12. You have free access to this content12
    Richard Platt, Ryan M. Carnahan, Jeffrey S. Brown, Elizabeth Chrischilles, Lesley H. Curtis, Sean Hennessy, Jennifer C. Nelson, Judith A. Racoosin, Melissa Robb, Sebastian Schneeweiss, Sengwee Toh, Mark G. Weiner, The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction, Pharmacoepidemiology and Drug Safety, 2012, 21,